Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 1, 2006, Pages 1-7

  Wehr, H ^a,d   Bednarska Makaruk, M ^a   Lojkowska W ^b   Graban, A ^b   Hoffman Zacharska, D ^c   Kuczynska Zardzewialy A ^a   Mrugala J ^a   Rodo, M ^a   Bochynska A ^b   Sulek A ^a   Ryglewicz, D ^b  

^a Wolski Hospital   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c INSTITUTE OF MOTHER AND CHILD   (Poland)

^d NONE   (Poland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Interleukin 1 lipids; Mixed dementia; Vascular dementia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA 2 MACROGLOBULIN; ANTIBODY; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIXED DEMENTIA; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; DEMENTIA; DEMENTIA, VASCULAR; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPIDS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; TRIGLYCERIDES;

EID: 33745206759     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092845     Document Type: Article

References (35)

1. Kalaria R: Similarities between Alzheimer's disease and vascular dementia. J Neurol Sci 2002;203-204:29-34.
2. Korczyn AD: The underdiagnosis of the vascular contribution to dementia. J Neurol Sci 2005;229-230:3-6.
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
4. Rubinsztein DC, Easton FE: Apolipoprotein variation and Alzheimer disease: a metaanalysis. Dementia Geriatr Cogn Disord 1999;10:199-209.
5. Ashford JW, Mortimer JA: Non-familial Alzheimer's disease is mainly due to genetic factors. J Alz Dis 2002;4:169-177
6. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck W, Hyman BT, Strickland DK: Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). J Biol Chem 2000;275:7410-7415.
7. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R: Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 1997;49:56-61.
8. Baum L, Chen L, Ng HK, Chan YS, Mak YT, Woo J, Chiu HFK, Pang CP: Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer disease in Chinese. Neurosci Lett 1998;247:33-36.
9. McElroy SP, Dynan KB, Vahidassr DJ, Lawson JT, Patterson CC, Passmore P: Common polymorphism in LRP and α2M gene do not affect genetic risk for Alzheimer disease in Northern Ireland. Am J Med Genet 2001;105:502-506.
10. Lendon CL, Talbot CJ, Craddock NJ, Han SW, Wragg M, Morris JC, Goate AM: Genetic association studies between dementia of Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997:222:187-190.
11. Lambert JC, Chartier-Harlin MC, Cottel D, Richard F, Neuman E, Guez D, Legrain S, Berr C, Amouyel P, Helbecque N: Is the LDL receptor-related protein involved in Alzheimer's disease? Neurogenetics 1999;2:109-113.
12. Scott WK, Yamaoka LH, Bass MP, Gaskell PC, Conneally PM, Small GW, Farrer LA, Auerbach SA, Saunders AM, Roses AD, Haines JL, Pericak-Vance MA: No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease. Neurogenetics 1998;1:179-183.
13. Verpillat P, Bouley S, Campion D, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Agid Y, Brice A, Clerget-Darpoux F: Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population. Eur J Hum Genet 2001;9:464-468.
14. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RCP, Perry R, Watson B, Basset S, McInnis MG, Albert M, Hyman BT, Tanzi RE: Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998;19:357-360.
15. 2-macroglobulin (Val1000Ile) polymorphism and Alzheimer disease. Hum Mol Genet 1998;7:1953-1956.
16. 2-macroglobulin gene in AD: a population based study and meta-analysis. Neurology 2000;55:678-684.
17. 2-macroglobulin. Hum Mol Genet 2003;12:2765-2776.
18. Reiss BA, Siller KA, Rahman MM, Chan ESL, Ghiso J, de Leon MJ: Cholesterol in neurologic disorders in the elderly: stroke and Alzheimer's disease. Neurobiol Aging 2004;25:977-989.
19. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VI, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
20. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
21. Hatanaka Y, Kamino K, Fukuo H, Mitsuda N, Nishiwaki O, Ueda Y, Sato N, Satoh T, Yamamoto H, Yoneda H, Imagawa M, Miki T, Ohta S, Ogihara T: Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population. Clin Genet 2000;58:319-323.
22. 2- macroglobulin gene. Clin Chem 1999;45:307.
23. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S, Uchokoshi T: Genetic polymorphisms of interleukin-1β in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 2000;95:1305-1311.
24. Lindpainter K, Pfeffer MA, Kreutz R, Stamper MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
25. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
26. Isoe K, Urakami K, Sato K, Takahashi K: Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand 1996;93:133-137.
27. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K: Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dementia Geriatr Cogn Disord 1998;9:243-245.
28. Wehr H, Parnowski T, Pużyński S, Bednarska-Makaruk M, Bisko M, Kotapka-Minc S, Rodo M, Wołkowska M: Apolipoprotein E genotype and lipid and lipoprotein level in dementia. Dementia Geriatr Cogn Disord 2000;11:70-73.
29. McGeer PL, McGeer EG: Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 2001;58:1790-1792.
30. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A Taqi polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992;22:396-402.
31. Hu J, Igarashi A, Kamata M, Nakagawa H: Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ), retards Aβ aggregation, deposition, fibril formation and inhibits cytotoxicity. J Biol Chem 2001;276:47863-47868.
32. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PWF, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
33. Religa D, Styczyńska M, Poplońska B, Gabryelewicz, Pfeffer A, Chodakowska M, Łuczywek E, Wasiak B, Stȩpień K, Gołȩbiowski M, Winblad B, Barcikowska M: Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dementia Geriatr Cogn Disord 2003;16:64-70.
34. Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B, Spada R, Caraci F, Pourie G, Daval JR, Ferri J: Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004;15:859-961.
35. Davignon J, Cohn JS, Mabile L, Bernier L: Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999;286:115-143.